Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Amazon is set to lose two important executives who were said to have played a role in the company’s foray into the health care business. It is also shutting its telehealth service this year.
As per CNBC, the two executives were the co-founders of PillPack online pharmacy startup as well, and they are TJ Parker and Elliot Cohen. Amazon acquired the pharmacy in 2018 for around $750 million, and the co-founders came aboard the e-commerce and tech firm as health strategy advisors.
When the acquisition was completed, the two worked with Amazon to help launch its Amazon Pharmacy, an online shop for medicines which delivers prescription drugs in the United States. Parker and Cohen were the vice president of the said pharmacy before they were moved to consulting roles recently.
Now they are both leaving Amazon at the end of this month. They have personally announced their departure through a note they sent to their team at the company on Tuesday, Sept. 20.
“I’m officially moving on from PillPack / Amazon. I’m so proud of what we have accomplished over the last decade and am filled with gratitude,” Parker wrote on LinkedIn with his full note to the team attached.
In recent years, Amazon has scaled up its push into the health care business, however, only part of its efforts was successful. It was reported that its pharmacy unit is struggling to secure its share in the market while Amazon has decided to fully shut down its Amazon Care telehealth service business.
Parker said that he and Cohen are likely to take a rest and spend more time with their families. Later on, they will both return to invest, start a new business, and give advice to healthcare and consumer-focused businesses.
For the departure of Parker and Cohen, Amazon’s health care operation’s veteran executive, Neil Lindsay, sent an email to employees. He said that their exit from the company is “bittersweet” and expressed gratitude for helping them develop the strategy for a better consumer health care experience.
“TJ and Elliot have had a significant impact on Amazon and the Health Services organization, and while they will be missed, we’re grateful for their contributions and wish them well on their next endeavors,” Bloomberg quoted Lindsay as saying in the email.
